clinical trial · NCT06841731
A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
Jiangsu HengRui Medicine Co., Ltd.·phase2·completed·n = 120
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)HRS-8427Meropenem
brief summary
The purpose of this study is to evaluate the efficacy and safety of HRS -8427 in patients with HABP/VABP.
started
Apr 10, 2025
primary completion
Sep 22, 2026
completion
Oct 9, 2026
last updated
Oct 22, 2026
official title
A Multi-center, Randomized, Double-blind, Active Controlled, Parallel Groups, Phase II Study to Evaluate the Efficacy and Safety of HRS-8427 in the Treatment of Adults With Hospital-acquired Bacterial Pneumonia (HABP) or Ventilator-associated Bacterial Pneumonia (VABP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol